Business
MjMicro Conference Sold Out for Presenting Companies, Underscores Increasing Demand in Booming Cannabis Sectors
MjMicro Conference Sold Out for Presenting Companies, Underscores Increasing Demand in Booming Cannabis Sectors.
About this update from Decentral Life, Inc.
[{"type":"text","content":"\nNEW YORK, May 22, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsWire -- MjMicro Conference (www.mjmicro.com), the next-level investor forum for publicly traded cannabis companies, is sold out for Presenting Companies. MjMicro, set to take place on June 25, 2019, at the Westin Grand Central in New York City, promises to unite carefully vetted cannabis-related public entities with a full roster of potential investors.\n The MjMicro Conference is an invitational networking forum exclusively created to enable best-in-class and emerging public companies in the cannabis industry to meet with high-net-worth investors, venture funds and family offices, helping drive private investment capital into public entities, promote trading liquidity, and increase media and analyst coverage. “This event is by invitation on both sides of the table as part of our mission is to parse out the best opportunities for our audience of investors,” noted George Jage, president and COO of MjLink.com and producer of MjMicro. “The demand by the market confirms that the cannabis industry needs its own public market capital conference to showcase one of the fastest growing industries in the world.” Presenting companies include: Emerald Health TherapeuticsFSD PharmaFlowr Corp.1933 Industries48North CannabisCannAmerica BrandsCANNEX Capital Holdings / 4FrontCardiol Therapeutics Inc.Dixie BrandsEXMceuticalsHelix TCS Inc.HighTide Inc.House of JaneMJ FreewayPhoenix Life Sciences Int’l Ltd.Province Brands of CanadaTauriga SciencesUnited Cannabis Corp.Vireo Health “We have an exciting mix of companies ranging from $5 million to $500 million in market caps, and companies involved in cultivation, multi-state operators, technologies, lifestyle products and the emerging cannabis beverage category,” noted Todd Markey, director of investor relations at MjMicro. “With the expected growth trajectory of cannabis and hemp, this offers the investors a variety of developmental stages and channels in which they can invest into these companies.” In the next decade, analysts project that total cannabis industry sales could reach as high as $130 billion. Viridian Capital Advisors, a leading cannabis investment bank, estimates that $13.8 billion was raised by cannabis firms in 2018, marking a 4-fold increase over the year prior. MjMicro...